Sellas Life Sciences Group Inc (SLS) stock news · $1.62B cap
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
This SLS news page leads with what Sellas Life Sciences Group Inc filed — not a scraped headline mill.
No cached 8-K sentence for SLS yet. We will not pad this page with generic market recap.
Latest reported SLS revenue for 2023-12-31 was $0. Net income was -$37.3M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. SLS currently screens at market cap $1.62B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SLS stock page; for the tape open the quote page.
SLS stock news FAQ
What is SLS's latest net income?
Latest cached Sellas Life Sciences Group Inc (SLS) net income was -$37.3M. Statements: https://lician.com/financials/sls
What is SLS's market cap?
Sellas Life Sciences Group Inc (SLS) market cap is $1.62B on the latest cached fundamentals snapshot.
What kind of company is SLS?
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Where is SLS stock news listed?
Cached stock news for Sellas Life Sciences Group Inc (SLS) is listed at https://lician.com/news/sls. Filings: https://lician.com/sec/sls
Not investment advice.